GeoVax announced its patent in Atlanta, utilizing CSP protein in its vaccine design, with David Dodd serving as CEO.
1 report, 0 independent
Updated Jun 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GeoVax announced its patent in Atlanta, utilizing CSP protein in its vaccine design, with David Dodd serving as CEO.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GeoVax
biotechnology company
Nothing else this week.
-
David Dodd
Australian soccer player
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet